Stock Information
4D Molecular Therapeutics Inc (FDMT)
Ticker Symbol: FDMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $550.85 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -2.6974
Revenue (TTM): $1.30 M
Dividend Yield: N/A%
ROE: -36.83%
Latest News
-
4DMT Announces New Employment Inducement Grants
Fri, May 15, 2026 4:05 PM
-
4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wed, May 13, 2026 7:40 PM
Key Financials
Financial data not available